Clinical Trials Logo

Clinical Trial Summary

To evaluate the influence of circadian rhythm on progesterone levels during follicular phase of natural cycle and during follicular phase of controlled ovarian stimulation during IVF.


Clinical Trial Description

The primary aim of this study is to determine the circadian rhythm of progesterone in a stimulated cycle. Sample size calculations show that the study needs to recruit 10 women to show any significant differences in progesterone secreted in the morning at 8 am compared to that secreted in the evening at 8 pm. We have increased the number of participants to 12 in order to compensate for any possible drop outs. The hormones FSH, LH, Progesterone and Estradiol will be measured at days 2/3, 8, 10 and 12 of a normal and stimulated cycle so that each patient serves as her own control.

This study will provide the basis to establish the optimal blood sampling time for progesterone measurement and to more accurately determine the cut-off level for progesterone for favourable pregnancy outcomes in ART. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02975713
Study type Observational
Source IVI Middle East Fertility Clinic
Contact
Status Terminated
Phase N/A
Start date November 2, 2017
Completion date November 15, 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04002141 - Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis Phase 2
Recruiting NCT02715336 - Efficacy and Safety of Medication Used to Stimulate Ovulation Phase 4
Completed NCT03473613 - Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention Phase 3
Completed NCT04175990 - IVF Outcome Following Progestogen Ovarian Stimulation Phase 1
Not yet recruiting NCT02416596 - Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility N/A